First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Trial StartPositive

AI Analysis

Summary

Ananda Pharma Limited announced the first patient dosing in a clinical trial for chemotherapy induced peripheral neuropathy using cannabidiol. The UK-based company is developing cannabidiol medicines for CIPN and endometriosis.

Clinical Trial Data

Importance:3/10

Sentiment:

0.30

CIPNcannabidiolclinical trialfirst patient dosedUK biotech

Related Companies

$TRAX

Read the original article

Published by PR Newswire Pharma on July 17, 2026 8:39 AM

Read Original